Shoulder Innovations, Inc. Common Stock (SI)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- P/B of 3.32 — trading above book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -30.8%
- Revenue growing at 50% annually
Shoulder Innovations, Inc. Common Stock (SI) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $441 million . Key value metrics: P/B ratio 3.32, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Shoulder Innovations, Inc. Common Stock — Fundamental Analysis Summary
On financial health, SI shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -30.8% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.11.
StockPik's composite Value Score for SI is 57/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SI reports a high gross margin of 76.9% (sector average: 39.4%) and a negative operating margin of -54.0%.
SI shows revenue growing at 50% year-over-year, with earnings declining at 158%.